P55 | MANAGEMENT OF NEUROLOGICAL TOXICITIES OF PATIENTS TREATED WITH IMMUNOTHERAPIES FOR MULTIPLE MYELOMA: A SINGLE-CENTER REAL WORLD EXPERIENCE
T cell redirecting therapies (TCRt) have dramatically improved the prognosis of relapsed/refractory multiple myeloma (RRMM) patients (pts), but they are also burdened by novel toxicities, among which neurological ones such as immune cell associated neurotoxicity syndrome (ICANS), headache, and neur...
Gorde:
| Egile Nagusiak: | , , , , , , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Ferrata Storti Foundation
2026-04-01
|
| Saila: | Haematologica |
| Sarrera elektronikoa: | https://haematologica.org/article/view/14068 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|